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Abstract
Aims: To study the incidence of perinatal stroke in a level-III maternity 
as well as potential risk factors, clinical presentation, neuroimaging, 
classification and clinical outcome of children with a minimum follow-up of 
24 months.
Methods: Historical prospective follow-up of all term and late preterm 
newborns diagnosed with perinatal stroke from January 2008 to December 
2013.
Results: Fifteen perinatal strokes were diagnosed in a total of 17,056 
newborns (incidence 0.9/1,000). Thirteen had potential risk factors and fourteen 
were symptomatic. Median age at diagnosis was two days. Seizures were 
the most frequent symptom (14/15), being three focal-clonic, one multifocal-
clonic, two generalized-tonic, three focal-tonic and five subtle. Cerebral 
ultrasound was performed in eleven newborns at an early stage, suggesting 
the diagnosis in six. Cerebral magnetic resonance imaging (MRI) confirmed 
the diagnosis in fifteen. Six had an arterial ischemic stroke, eight a cerebral 
venous thrombosis and one a hemorrhagic stroke. An electroencephalogram 
was obtained in all newborns with seizures revealing epileptic activity in eight. 
Search for prothrombotic disorders (in newborn and both parents) showed 
four newborns heterozygous methylene tetrahydrofolate reductase mutation 
and two neonatal alloimune thrombocytopenia. No recurrence of stroke was 
reported. Formal development evaluation was performed in thirteen and was 
normal in eleven, while in two revealed delayed psychomotor development, 
both of which with epilepsy. On the neonatology outpatient clinic follow-up, 
the current median age is 3 years and 11 months.
Conclusions: This study reinforces the need to maintain high level of 
suspicion for perinatal stroke and the importance of MRI in the classification 
and etiological study. Our follow-up supported a good outcome of perinatal 
stroke.
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Introduction
Perinatal stroke can be defined as an acute 
neurologic syndrome due to cerebral injury of 
vascular origin occurring between 20th week of 
gestation and day 28th of postnatal life [1, 2]. Three 
subcategories were defined, incorporating the 
timing of the condition. “Fetal ischemic stroke” 
is diagnosed before birth using fetal imaging 
methods. “Neonatal stroke” is diagnosed after birth 
and before day 28th postnatal. “Presumed perinatal 
stroke” is diagnosed in infants with more than 28 
days of life in whom it is presumed, but not certain, 
that the stroke occurred sometime from 20th week 
of gestation through day 28th postnatal [3-5]. Also, 
there are three major clinical-anatomic subtypes: 
arterial ischemic stroke, hemorrhagic stroke, and 
cerebral venous thrombosis [3-5].
Perinatal stroke is not rare. In fact, stroke is 
17 times more common in the perinatal period 
than later in childhood or beyond [6]. The usual 
distribution of the different types of stroke are: 
70% arterial ischemic, 20% hemorrhagic and 
10% cerebral venous thrombosis [4, 5]. Despite 
the results published concerning incidence, it is 
likely to be underestimated as it is largely based on 
retrospective cohort studies. 
The etiology is complex and multifactorial 
with many potential risk factors being described. 
Maternal, placentar, fetal/neonatal and delivery 
risk factors are present in up to 75% of cases [4]. 
Age of diagnosis depends on stroke location. The 
most common presenting clinical signs are seizures, 
altered mental status and abnormal tone. Others 
may present hemiparesis or even respiratory and 
feeding difficulties [7].
In relation to diagnosis, magnetic resonance 
imaging (MRI) is the most sensitive imaging 
modality for detection of stroke and is therefore 
the goal standard [8]. As recurrence rates are low, 
treatment of perinatal stroke has been largely 
supportive. Few data exist about the use of 
anticoagulation therapy after stroke [9, 10]. 
Outcomes of perinatal stroke are generally 
poor, being the most common cause of hemiparetic 
cerebral palsy and other additional sequelae, 
including intellectual disabilities, developmental 
and behavioral disorders, and epilepsy. Children 
with perinatal stroke are considered to grow into 
their deficits when specific developmental stages 
are reached [11].
Aims
The purpose of this study was to determine the 
incidence of perinatal stroke in a level-III maternity 
as well as potential risk factors, clinical presentation, 
neuroimaging, lesion classification and clinical 
outcome of children with a minimum follow-up of 
24 months. 
Patients and methods
For the current historical prospective study, full-
term and late pre-term newborns (≥ 34 gestational 
week) admitted to the neonatal unit of Hospital de 
Braga with a stroke diagnosed during the first 28 
days of life and confirmed by neuroimaging between 
January 2008 and December 2013 were included. 
Follow-up consisted of a structured neurologic and 
developmental assessment (Schedule of Growing 
Skills II, Wechsler Intelligence Scale for Children 
or Griffiths Mental Development Scales). Exclusion 
criteria were hypoxic-ischemic encephalopathy with 
criteria for therapeutic hypothermia and/or posterior 
diagnosis of an inborn error of metabolism. The 
incidence of stroke diagnosis was calculated based 
on the Hospital de Braga statistical office (number 
of perinatal stroke in relation to births during the 
study period). Results are presented with descriptive 
statistics.
Results
Fifteen perinatal strokes were diagnosed during 
this period (incidence of 0.9/1,000). The sex ratio 
was 8:7 (F:M) and mean duration of hospitalization 
was 16.4 days (minimum of 7 days, maximum of 
51 days).
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Cranial ultrasound was performed at an early 
stage in eleven of the fourteen newborns with 
seizures, being unremarkable in five and altered in 
six. Cranial ultrasound revealed abnormal features 
in one hemorrhagic stroke (right temporo-occipital 
parenchymal hematoma), one ischemic stroke (left 
supratentorial hypoxic-ischemic lesion) and in 
four cerebral venous thrombosis (subependymal 
hemorrhage, left thalamic hematoma, right fronto-
parietal hypoxic-ischemic lesion, intraventricular 
hemorrhage). The remaining four patients performed 
an MRI as first workup exam. Overall, MRI was 
performed in all cases (T1, T2 and diffusion-
weighted imaging), complemented with gadolinium 
venography when cerebral venous thrombosis 
was suspected. It was successfully performed 
using chloral hydrate and allowed to diagnose six 
arterial ischemic strokes (two with hemorrhagic 
transformation and three showing evidence of 
wallerian degeneration), one hemorrhagic stroke 
and eight cerebral venous thromboses (seven 
with hemorrhagic transformation) (Figures 1-4). 
Regarding the arterial ischemic strokes, the middle 
cerebral artery was affected in four and the posterior 
cerebral artery in two, being all strokes cortico-
subcortical. The newborn with hemorrhagic stroke 
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Table 1. Risk factors.
Sex GA
Potential risk factor
MA Primiparity Placenta/AF Delivery Resuscitation Apgar score Other
1 F 37 36 N - Eutocic - 9/10 +AP Mab; MT
2 M 34 33 Y Meconium Cesarian - 9/10 Gestational diabetes
3 F 38 32 Y - Eutocic - 9/10 Patent FO; MT
4 M 41 34 Y - Ventouse - 8/10 MT
5 M 38 25 N - Eutocic - 9/10 N
6 F 37 33 Y - Eutocic - 9/10 IUGR
7 F 38 42 N - Cesarian - 10/10 +AP Mab; MT
8 F 35 39 Y - Eutocic - 9/10 H – MTHFR
9 F 38 32 Y - Cesarian - 8/9 Infertility
10 M 40 34 N - Forceps - 9/10 H – MTHFR; patent FO
11 F 41 34 Y - Cesarian - 10/10 N
12 F 39 42 N - Eutocic - 10/10 Gestational diabetes; MT
13 M 41 24 Y - Eutocic + 6/10 H – MTHFR
14 M 38 19 Y Meconium Cesarian - 8/10 N
15 M 39 17 N - Eutocic - 8/10 H – MTHFR
F: female; M: male; GA: gestational age; MA: maternal age; N: no; Y: yes; AF: amniotic fluid; +AP Mab: positive anti-platelet maternal 
antibody; MT: maternal thrombocytopenia; FO: foramen ovale; IUGR: intra-uterin growth restriction; H – MTHFR: heterozygotic MTHFR.
Patients identification number corresponds to the number in Tab. 2 and in Figures 2-5.
Potential risk factors were present in thirteen 
newborns. Maternal and placentar risk factors 
included one case of infertility, nine primipara 
women, four with advanced maternal age (≥ 35 
years), five maternal thrombocytopenia and two 
gestational diabetes. Fetal and perinatal risk factors 
were one intrauterine growth restriction, presence of 
meconium in the amniotic fluid in two, need of early 
neonatal resuscitation in one and two newborns with 
patent foramen ovale. In this series, there were seven 
dystocic deliveries. The median gestational age was 
38 weeks and there were two cases of premature 
delivery at week 34 and 35 of gestation. Risk factors 
are summarized on Tab. 1. Of the fifteen newborns, 
fourteen were symptomatic presenting seizures. 
Only one had an incidental diagnosis which 
occurred during the study of a suspected cranial 
fracture (patient 9, Tab. 2). Seizures were classified 
as subtle in five, focal clonic in one, subtle and focal 
clonic in two, subtle and generalized tonic in one, 
multifocal clonic in one, generalized tonic in one and 
focal tonic in three newborns. Nine were hypotonic. 
Other presenting symptoms were irritability in two, 
feeding difficulties in two and hemiparesis in one 
newborn. The mean age of diagnosis was 3.1 days 
(standard deviation of 3.9 days). 
4/9
Journal of Pediatric and Neonatal Individualized Medicine • vol. 6 • n. 2 • 2017www.jpnim.com Open Access
Teixeira • Sá • Antunes • Costa • Barbosa • Fernandes • Pereira
and deep cerebral and transmedular veins in two 
patients. In total, nine strokes were left, four right 
and two bilateral. An electroencephalogram (EEG) 
was obtained in all newborns with seizures revealing 
epileptic activity in eight.
The search for prothrombotic disorders were 
performed in all cases (newborn and both parents), 
and showed four newborns heterozygous methylene 
tetrahydrofolate reductase mutation and two 
neonatal alloimune thrombocytopenia (patient 1 
and 2). Cardiac evaluation was performed in all 
newborns and revealed two patent foramen ovale. 
No clinical recurrence of stroke was reported. 
Management of perinatal stroke was supportive. 
Adequate oxygenation and ventilation was ensured. 
Table 2. Description of patients.
Patient Type of stroke Seizure
Clinical presentation Neuroimaging
Bradycardia Tone Other Transfontanellar US Vascular territory
1 I → H Subtle Y Hypotonic - Normal MCA – L
2 T → H Subtle + Focal clonic N Hypertonic
Irritability 
+ Diabetes 
insipidus
Subependymal 
hemorrhage
Superior longitudinal 
and left transverse 
VST 
3 T → H
Subtle + 
Generalized 
tonic
Y Hypertonic - Left thalamic hematoma Left thalamic vein 
4 I [WD] Focal clonic N Hypotonic - Normal MCA – L
5 T → H Focal tonic Y Hypotonic Feeding difficulties Normal
Superior longitudinal 
and right lateral VST 
6 T → H Focal tonic Y Hypotonic -
Right fronto-parietal 
hypoxic-ischemic 
lesion
Superior longitudinal 
and right transverse 
and sigmoid VST 
7 H Subtle Y Hypotonic -
Right temporo-
occipital parenchymal 
hematoma
Multiple 
supratentorial 
hematomas
8 T Subtle N Hypotonic - Normal
Superior longitudinal 
and left transverse 
VST 
9 T → H - N Normal
Suspected 
cranial 
fracture line
- Superior longitudinal VST
10 I [WD] Generalized clonic N Hypotonic - Normal MCA – R
11 I Subtle N Hypertonic - - PCA – L
12 T → H Generalized tonic N Hypertonic - -
Deep cerebral and 
left transmedullary 
veins
13 I → H Focal tonic N Hypotonic Hemiparesis - MCA – L
14 I [WD] Subtle + Focal clonic Y Hypotonic
Irritability 
+ Feeding 
difficulties
Left supratentorial 
hypoxic-ischemic 
lesion
PCA/MCA - L
15 T → H Sublte N Hypertonic Irritability Intraventricular hemorrhage Deep cerebral veins
I: ischemic; H: haemorrhagic; T: thrombosis; WD: wallerian degeneration; Y: Yes; N: No; MCA: middle cerebral artery; L: left; VST: venous 
sinus thrombosis; R: right; PCA: posterior cerebral artery.
Patients identification number corresponds to the number in Tab. 1 and in Figures 2-5.
Cerebral venous thrombosis (n = 8; 53%) Pe
rin
at
al 
str
ok
e 
(n
 =
 1
5) Arterial ischemic (n = 6; 40%)
Hemorrhagic (n = 1; 7%)
Figure 1. Flow-chart: types of stroke in our cohort.
had multiple supratentorial hematomas. Cerebral 
venous thrombosis occurred in the superior 
longitudinal sinus in five, thalamic vein in one 
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Figure 2. Six cases of arterial ischemic strokes. Patient 1: axial diffusion-weighted image (DWI) reveals left middle cerebral 
artery (MCA) ischemic stroke; patient 4: axial DWI reveals left MCA ischemic stroke; patient 10: axial DWI reveals right 
MCA ischemic stroke; patient 11: axial DWI reveals left posterior cerebral artery (PCA) ischemic stroke; patient 13: axial 
T2-weighted image reveals left MCA ischemic stroke; patient 14: axial DWI reveals left MCA and PCA ischemic stroke. 
Patients identification number corresponds to the number in Tables 1 and 2.
Figure 3. One case of hemorrhagic stroke. Axial T1-weighted image reveals a right parietal-occipital and left temporal 
hemorrhagic stroke (both images correspond to patient 7).
Patient identification number corresponds to the number in Tables 1 and 2.
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Seizures were treated with phenobarbital in ten and 
a combination of phenobarbital and phenytoin was 
needed in four to achieve seizures remission. On 
average, anticonvulsants were stopped by the age 
of 5 months (minimum of 1 month; maximum of 
10 months). 
None was treated with anticoagulants. There 
were no deaths registered among newborns with 
perinatal stroke. 
All patients were sent to the neonatology 
outpatient clinic, notwithstanding a formal 
development evaluation was not performed in 
two (patients 8 and 15), one of which abandoned 
follow-up at 12 months of age. Imaging follow-up 
was performed in five patients with MRI and in four 
patients with transfontanelar US. Physical medicine 
and rehabilitation evaluated the entire cohort: 
physiotherapy was prescribed in seven newborns 
(patients 1-3, 5-7, 12; average therapy duration 
was fourteen months) and speech therapy in four 
(patients 1, 2, 5 and 15). Development evaluation was 
performed in thirteen, using Schedule of Growing 
Skills II, Wechsler Intelligence Scale for Children 
(WISC-III) or Griffiths Mental Development Scales. 
The average age at this evaluation was 3 years 
and 8 months (minimum 23 months, maximum 
of 6 years). It was normal in eleven (patients 1, 
3, 4, 6, 7, 9-14), while in two revealed delayed 
psychomotor development (patients 2 and 6). The 
last two presented cerebral venous thrombosis 
with hemorrhagic transformation and symptomatic 
epilepsy, one of which also had a mild brachial 
predominance right hemiparesis (patient 2).
The patients average current age is 3 years and 
11 months (minimum 24 months, maximum 7 
years). Schematic follow-up of patients is presented 
in Fig. 5.
Discussion
This study describes the clinical presentation 
and follow-up of a group of newborns with perinatal 
stroke who were born in our center. In none of these 
newborns was possible to distinguish between 
fetal or neonatal stroke. Fetal stroke, or that which 
occurs between 14 weeks of gestation and the 
onset of labor, can be diagnosed when a stroke is 
detected prenatally by ultrasonography and should 
always be confirmed by prenatal MRI. We found 
a higher incidence of neonatal stroke compared to 
the reported literature [11], particularly related to 
cerebral venous thrombosis etiology [3, 6, 12], which 
we relate to our accessibility to MRI. Although 
Figure 4. Eight cases of cerebral venous thromboses. Pa-
tient 2: axial T2-weighted image reveals a bilateral thalamic 
hemorrhagic stroke; patient 3: axial T2 reveals a left 
thalamic hemorrhagic stroke; patient 5 (a): axial T1 reveals a 
bilateral parietal hemorrhagic stroke; patient 5(b): magnetic 
particle imaging (MIP) reveals a superior longitudinal and 
lateral venous sinus thrombosis (VST); patient 6 (a): axial 
T2 reveals a frontal hemorrhagic stroke; patient 6 (b): MPI 
image reveals a superior longitudinal and right transverse 
and sigmoid VST; patient 8: MPI image reveals a superior 
longitudinal and left transverse VST; patient 9: sagittal T1 
reveals a parietal hemorrhagic stroke; patient 12: axial T2 
reveals an occipital hemorrhagic stroke; patient 15: axial T1 
reveals an intraventricular hemorrhage.
Patients id number corresponds to the number in Tables 1 and 2.
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several potential risk factors have been associated 
with perinatal stroke, little is known about the exact 
pathophysiological mechanisms responsible for 
most cases and most potential risk factors have been 
identified in small retrospective case series which 
do not necessarily reflect a causal relation [13-15]. 
In our study we found these potential risk factors in 
thirteen patients. There was a significant percentage 
of dystocic delivery (7 patients) which is known to 
be a major risk for stroke. Nevertheless, two patients 
had more than one risk factor, which supports the 
hypothesis that this is a multifactorial condition [14, 
16, 17]. The clinical presentation of perinatal stroke 
varies from nonspecific to obvious neurological 
symptoms, which may make the diagnosis difficult 
[16-19]. In our series, seizures were the most 
common clinical manifestation, which is consistent 
with the published data [6, 19-21]. As described in 
literature, seizures are common in association with 
ischemia in children, especially newborns, and are 
generally the most common clinical finding that 
leads investigations in neonates. In one patient, the 
event was clinically silent [7]. The majority were 
symptomatic within the first 48 hours of life, which 
should be the period of greatest suspicion of stroke.
Neonatal neuroimaging plays an important 
role in both diagnosis and prognosis. Modern 
neuroimaging has greatly improved the detection 
and understanding of perinatal stroke. The most 
accurate method for detecting stroke is MRI and 
thus it is the exam of choice [6, 17, 22]. In our study, 
assessment by neuroimaging methods was based on 
the cranial ultrasound and MRI. MRI was performed 
very early due to its good accessibility and the low 
sensitivity of cranial ultrasound for stroke at an early 
stage. Vascular lesions were often distributed on the 
left side (9 patients), which is consistent with the 
literature data that refers a predominance of the left 
side lesions due to differences in vulnerability and 
maturation, or the presence of vascular asymmetry 
[18, 19]. It is also thought that left hemisphere may 
be more vulnerable to embolic lesions [18, 19]. 
Standard EEG should be done in case of 
suspicion of epileptiform activity, as it is usually 
the first diagnostic tool available for assessment of 
brain function [16, 19, 21]. Continuous EEG was 
not available in our unit during the study period.
Management of perinatal stroke is not yet 
established and there is still ongoing discussion 
on whether anticoagulants should or should not 
be used [5]. The American College of Chest 
Physicians recommends anticoagulation therapy in 
newborns with a first ischemic stroke if evidence 
of an ongoing cardioembolic source is documented, 
Perinatal stroke: a six-year experience in a level-III maternity
Figure 5. Flow-chart: schematic follow-up of patients.
T: trombosis; H: haemorrhagic;Y: years; m: months.
Patients identification number corresponds to the number in Tables 1 and 2.
Patient 5 
Symptomatic 
epilepsy (6 m)
15 perinatal 
strokes
13 followed 
(median current 
age 3 Y + 11 m)
11 normal 
developmental 
evaluation
2 abandoned 
follow-up
6 arterial ischemic 
stroke
4 cerebral venous 
thrombosis  
1 hemorrhagic 
stroke
2 delayed 
psychomotor 
development
(T → H) 
Patient 2
Symptomatic 
epilepsy (7 m) 
and mild brachial 
predominance 
right hemiparesis
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and in the case of cerebral venous thrombosis in the 
absence of relevant intracranial hemorrhage [2, 9, 
10]. More recently, published guidelines support 
anticoagulation for neonatal cerebral venous 
thrombosis without hemorrhage, and for newborns 
with hemorrhage, either initial anticoagulation or 
clinical observation with early repeat imaging. 
At present, anticoagulation practice in cerebral 
venous thrombosis varies between countries [26]. 
Anticoagulation was not used in our series. In our 
series, all newborns had a normal cardiac evaluation. 
We had no significant number of patients with 
prothrombotic disorders, although screening has 
been made in all. 
Because most of the infants presented with 
seizures, the frequent use of anticonvulsants is 
expected [8]. In our study it was used in all that 
presented seizures (n = 14). Nowadays phenytoin 
is generally not used in neonates. There is a lack 
of guidelines regarding the optimal duration of 
anticonvulsant treatment. In our hospital, it was 
continued until no epileptiform activity was detected 
on EEG although debatable [18]. 
Beyond the neonatal period, therapy aims 
to prevent and treat sequelae and requires a 
multidisciplinary approach. Therapy should be 
started as soon as any neurologic sign or symptom 
is recognized. Epilepsy is another sequela described 
and requires adequate pharmacological approach. 
In relation to neurodevelopmental outcome, both 
short-term and long-term outcome mainly depends 
on the stroke extent and location [1]. Mortality rate 
tends to be low and recurrence is rare. No consensus 
exists on cognitive outcome, which may depend 
on the follow-up duration [3, 27]. In this series, 
most patients showed no neurological sequelae, 
being our follow-up a satisfactory indicator of 
the presence of some cognitive impairment. The 
relatively long follow-up of most patients is an asset 
of our study, confirming the overall good prognosis 
of perinatal stroke. Despite the recent progress, the 
pathogenesis remains unknown and therapies are 
lacking, mainly due to its low incidence. Further 
research studies and case-control studies should 
be performed to improve management and new 
therapies. 
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